Regulation
EmStop begins CAPTURE-2 trial of embolic protection system
EmStop has initiated the CAPTURE-2 IDE clinical trial to evaluate its embolic protection system in transcatheter aortic valve replacement (TAVR) procedures. The trial marks a key regulatory milestone in the development pathway for the device, which is designed to capture emboli during valve replacement interventions.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network